Messenger RNA (mRNA) based therapeutics have been in the last 10 years extensively exploited as attractive treatment against cancer. However, in vivo delivery of in vitro transcribed (IVT) mRNA can cause rapid production of type I interferon and trigger a counteracting effect. On one hand a strong innate immune response in induced, on the other this is know to reduce mRNA translation and thus possibly decrease the mRNA vaccine efficiency. Here, we enhanced mRNA biological activity improving mRNA translatability in the cell and lowering the in-vivo molecular immunogenicity.
Originele taal-2English
Aantal pagina's1
StatusPublished - 7 feb 2020
EvenementBACR Annual Meeting 2020: Cancer metastasis: From bedside to bench - Vrije Universiteit Brussel, Campus Jette, Brussels, Belgium
Duur: 7 feb 20207 feb 2020
Congresnummer: 26th


ConferenceBACR Annual Meeting 2020
Internet adres


Duik in de onderzoeksthema's van 'The impact of optimized mRNA on cancer vaccination'. Samen vormen ze een unieke vingerafdruk.

Citeer dit